Indexed In : Science Citation Index Expanded(SCIE), MEDLINE,
Pubmed/Pubmed Central, Elsevier Bibliographic, Google Scholar,
Databases(Scopus & Embase), KCI, KoreaMed, DOAJ
Gut and Liver is an international journal of gastroenterology, focusing on the gastrointestinal tract, liver, biliary tree, pancreas, motility, and neurogastroenterology. Gut atnd Liver delivers up-to-date, authoritative papers on both clinical and research-based topics in gastroenterology. The Journal publishes original articles, case reports, brief communications, letters to the editor and invited review articles in the field of gastroenterology. The Journal is operated by internationally renowned editorial boards and designed to provide a global opportunity to promote academic developments in the field of gastroenterology and hepatology. +MORE
Yong Chan Lee |
Professor of Medicine Director, Gastrointestinal Research Laboratory Veterans Affairs Medical Center, Univ. California San Francisco San Francisco, USA |
Jong Pil Im | Seoul National University College of Medicine, Seoul, Korea |
Robert S. Bresalier | University of Texas M. D. Anderson Cancer Center, Houston, USA |
Steven H. Itzkowitz | Mount Sinai Medical Center, NY, USA |
All papers submitted to Gut and Liver are reviewed by the editorial team before being sent out for an external peer review to rule out papers that have low priority, insufficient originality, scientific flaws, or the absence of a message of importance to the readers of the Journal. A decision about these papers will usually be made within two or three weeks.
The remaining articles are usually sent to two reviewers. It would be very helpful if you could suggest a selection of reviewers and include their contact details. We may not always use the reviewers you recommend, but suggesting reviewers will make our reviewer database much richer; in the end, everyone will benefit. We reserve the right to return manuscripts in which no reviewers are suggested.
The final responsibility for the decision to accept or reject lies with the editors. In many cases, papers may be rejected despite favorable reviews because of editorial policy or a lack of space. The editor retains the right to determine publication priorities, the style of the paper, and to request, if necessary, that the material submitted be shortened for publication.
Correspondence to: Jannis Kountouras
ORCID https://orcid.org/0000-0001-6459-5136
E-mail jannis@auth.gr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Gut Liver 2023;17(4):659-660. https://doi.org/10.5009/gnl220450
Published online March 14, 2023, Published date July 15, 2023
Copyright © Gut and Liver.
Τo overcome the influence of
Beyond the empirical first-line
After reviewing the abovementioned literature (although probably impossible), which may generate iatrogenic or even possible economic bias, such studies appear to be conducted without any potential novelty. Thus, the researchers may address the developing novel approaches, thereby recommending more effective strategies and evading citing the formerly recognized and repetitive data of increasingly ineffective antibiotic empirical or non-empirical combinations introduced. These combinations, beyond other critical concerns, render such monotonous studies rather insufficient for the regular reader.
Focusing on such previous studies, for instance, the Spanish group Hp-EuReg reported that the introduction of statins would not be sufficient to increase the
Concerning
Moreover,
Autophagy is involved in
Therefore, researchers should consider such abovementioned and additional novel approaches for treating
No potential conflict of interest relevant to this article was reported.
Gut and Liver 2023; 17(4): 659-660
Published online July 15, 2023 https://doi.org/10.5009/gnl220450
Copyright © Gut and Liver.
Second Medical Clinic, School of Medicine, Ippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
Correspondence to:Jannis Kountouras
ORCID https://orcid.org/0000-0001-6459-5136
E-mail jannis@auth.gr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Τo overcome the influence of
Beyond the empirical first-line
After reviewing the abovementioned literature (although probably impossible), which may generate iatrogenic or even possible economic bias, such studies appear to be conducted without any potential novelty. Thus, the researchers may address the developing novel approaches, thereby recommending more effective strategies and evading citing the formerly recognized and repetitive data of increasingly ineffective antibiotic empirical or non-empirical combinations introduced. These combinations, beyond other critical concerns, render such monotonous studies rather insufficient for the regular reader.
Focusing on such previous studies, for instance, the Spanish group Hp-EuReg reported that the introduction of statins would not be sufficient to increase the
Concerning
Moreover,
Autophagy is involved in
Therefore, researchers should consider such abovementioned and additional novel approaches for treating
No potential conflict of interest relevant to this article was reported.